TargImmune Therapeutics Revenue

Pharmaceutical Manufacturing • Basel, Basel, Switzerland • 1-10 Employees

TargImmune Therapeutics revenue & valuation

Annual revenue	$5,000,000
Revenue per employee	$715,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$16,000,000
Total funding	$19,300,000

Key Contact at TargImmune Therapeutics

Peter L. Braun

Chief Executive Officer

Company overview

Headquarters	Hochbergerstrasse 60c, Basel , BS 4057, CH
Phone number	+41615514500
Website	targimmune.com
NAICS	3254
SIC	873
Keywords	Oncology, Nanomedicine, Immunology, Targeted Drug Delivery
Founded	2016
Employees	1-10
Socials

TargImmune Therapeutics Email Formats

TargImmune Therapeutics uses 2 email formats. The most common is {first initial} (e.g., j@targimmune.com), used 50% of the time.

Format	Example	Percentage
{first initial}	j@targimmune.com	50%
{first initial}.{last name}	j.doe@targimmune.com	50%

About TargImmune Therapeutics

TargImmune Therapeutics AG is a private Swiss-based biotechnology company developing a novel targeted cancer treatment modality. TargImmune has a unique dsRNA non-viral vector delivery platform which, by mimicking a virus, harnesses the body's powerful antiviral defenses to address cancer tumors including distant metastases. The targeted nanoparticles drive a combination of apoptosis (cell death) and modulation of the innate and adaptive immune cells to target both primary and metastatic heterogeneous tumour cells. TargImmune’s therapeutics are the first in a new class known as Targeted Apoptotic Immune Modulators (TAIMs). TargImmune’s unique viral mimicry approach is fundamentally different to any of the other classes of anticancer agents in the clinic and has the potential to transform outcomes for cancer patients.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Head

C-Suite

Entry

Employees by Department

TargImmune Therapeutics has 4 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore TargImmune Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-08-19	1	$19,300,000

Funding Insights

$19,300,000

Total funding amount

$19,300,000

Most recent funding amount

Number of funding rounds

TargImmune Therapeutics Tech Stack

Discover the technologies and tools that power TargImmune Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Vue.js

JavaScript frameworks

Node.js

Programming languages

Nginx

Reverse proxies

Nuxt.js

JavaScript frameworks

Vimeo

Video players

core-js

JavaScript libraries

Webpack

Miscellaneous

Ubuntu

Operating systems

lit-element

JavaScript libraries

Google Maps

Maps

lit-html

JavaScript libraries

AOS

JavaScript libraries

Frequently asked questions

TargImmune Therapeutics is located in Basel, Basel, CH.

You can reach TargImmune Therapeutics at +41615514500.

TargImmune Therapeutics generates an estimated annual revenue of $5,000,000. This revenue figure reflects the company's market position and business performance in its industry.

TargImmune Therapeutics has an estimated valuation of $16,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

TargImmune Therapeutics was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

TargImmune Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

TargImmune Therapeutics has raised a total of $19,300,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at TargImmune Therapeutics

Peter L. Braun

Chief Executive Officer

4.8

40,000 users